Stay updated on Semaglutide Once-Daily Tablets in Overweight Clinical Trial
Sign up to get notified when there's something new on the Semaglutide Once-Daily Tablets in Overweight Clinical Trial page.

Latest updates to the Semaglutide Once-Daily Tablets in Overweight Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe footer identifies the ClinicalTrials.gov site as revision v3.8.0 instead of v3.7.2; the study record content appears unchanged.SummaryDifference0.1%

- Check24 days agoChange DetectedA notice appears at the top of the page describing NIH’s transition from the term “Artificial Intelligence” to “Super Intelligence” and linking to updates and FAQs.SummaryDifference0.6%

- Check31 days agoChange DetectedThe ClinicalTrials.gov site footer now displays revision v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check38 days agoChange DetectedThe site footer now identifies the website as revision v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check58 days agoChange DetectedRecord history shows a new revision from v3.6.6 to v3.7.0. This reflects an updated version of the record rather than changes to trial data or public-facing content.SummaryDifference0.1%

- Check80 days agoChange DetectedA new page revision, v3.6.6, was added to the study record history, and the previous revision v3.6.5 was removed from the listing.SummaryDifference0.1%

Stay in the know with updates to Semaglutide Once-Daily Tablets in Overweight Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Semaglutide Once-Daily Tablets in Overweight Clinical Trial page.